ALACIA SIMS: Open Payments
NPI 1427701556 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,484 in 60 payments from 16 companies in 2025. Trend: 2023 $883 · 2024 $1,495 · 2025 $1,484
Food & beverage: $1,484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $219 |
| Axsome Therapeutics, Inc. | 6 | $200 |
| LivaNova USA, Inc. | 3 | $159 |
| Teva Pharmaceuticals USA, Inc. | 5 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $139 |
| Neurocrine BioSciences, Inc. | 5 | $127 |
| Alkermes, Inc. | 4 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Tempus AI, Inc | 1 | $66 |
Products named: VRAYLAR, Auvelity, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, AUSTEDO XR, CAPLYTA, INGREZZA, REXULTI, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
